注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Prime Medicine Inc是一家总部位于美国的生物技术公司。该公司从事多种药物研发项目,针对肝脏、眼睛、体外造血干细胞和神经肌肉适应症。该公司的Prime Editing技术是一种解决遗传疾病原因的革命性技术。该公司的合作方式有助于对抗疾病,加速Prime Editing的发展,为患者提供治疗。它的Prime Editing被用来修改基因调控序列。这些编辑可以在与治疗相关的细胞和器官中进行,包括特化的终末分化细胞。它的Prime Editing就像一个脱氧核糖核酸(DNA)文字处理器,能够在基因组中精确位置搜索和替换基因序列,而无需在DNA中产生双链断裂。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Anastasia Khvovora | 54 | 2022 | Member of Scientific Advisory Board |
Agnieszka Czechowicz | - | 2022 | Member of Scientific Advisory Board |
David R. Liu | - | 2022 | Co-Founder & Chair of Scientific Advisory Board |
Wendy K. Chung | 54 | 2021 | Independent Director |
Robert Taylor Nelsen | 61 | 2020 | Independent Director |
Yvonne Chen | - | 2022 | Member of Scientific Advisory Board |
Keith Michael Gottesdiener | 69 | 2020 | President, CEO, Secretary & Director |
Eric N. Olson | - | - | Member of Scientific Advisory Board |
Kaye I. Foster-Cheek | 63 | 2021 | Independent Director |
Guangping Gao | - | 2022 | Member of Scientific Advisory Board |
David P. Schenkein | 66 | 2019 | Independent Director |
James Haber | - | 2022 | Member of Scientific Advisory Board |
Samuel H. Sternberg | - | 2022 | Member of Scientific Advisory Board |
Shengdar Q. Tsai | - | 2022 | Member of Scientific Advisory Board |
Jay Shendure | - | 2022 | Member of Scientific Advisory Board |
Michael A. Kelly | 66 | 2021 | Independent Director |
Muthiah Manoharan | 70 | 2022 | Member of Scientific Advisory Board |
Ben Kleinstiver | - | 2022 | Member of Scientific Advisory Board |
Thomas J. Cahill | 36 | 2021 | Independent Director |
Jeffrey D. Marrazzo | 44 | 2023 | Director |
Gerald Schwank | - | 2023 | Member of Scientific Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核